PlainPill

Kava

People mainly take Kava for anxiety, mood, sleep. Based on 104 first-hand reports and 41 meta-analyses & systematic reviews in the medical literature. Ranked #192 of 1,974 overall.

43
User score
Mostly positive
39% positive12% mixed8% negative40% unclear

Of reports that state an outcome, 66% are positive.

Clinical research
AStrong research base
41
meta-analyses
37
RCTs
815
papers

What Kava does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

BMC Psychiatry · 2020 · Meta-analysis / systematic review
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review

Conclusion: There is currently encouraging, albeit embryonic, evidence for medicinal cannabis in the treatment of a range of psychiatric disorders. Supportive findings are emerging for some key isolates, however, clinicians need to be mindful of a range of prescriptive and occupational safety considerations, especially if initiating higher dose THC formulas.

PubMed 31948424 ↗
World J Biol Psychiatry · 2022 · Meta-analysis / systematic review
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

Conclusion: Based on the current data and clinician input, a range of nutraceuticals and phytoceuticals were given either a supportive recommendation or a provisional recommendation across a range of various psychiatric disorders. However several had only a weak endorsement for potential use; for a few it was not possible to reach a clear recommendation direction, largely due to mixed study findings; while some other agents showed no obvious therapeutic benefit and were clearly not recommended for use. It is the intention of these guidelines to inform psychiatric/medical, and health professional practice

PubMed 35311615 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

sometimesas reported
1 bottle a dayas reported
occasional, as neededas reported
60 mg kavalactone equivalentdaily
1-2x/weekas reported
every other dayas reported

Reported side effects

How often each side effect came up across all reports.

stomach issues ×2drowsiness ×2anxiety ×2depression ×2liver damage ×1skin issues ×1liver dysfunction ×1leathery skin ×1

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“I've tried kava before but that gave me a stomach ache”
Source discussion ↗
“Kava has a definite affect on me, but didn’t budge any of my sleep scores.”
Source discussion ↗
“the other has a reverse tolerance but potentially fries your liver”
Source discussion ↗
“Another interesting study showing no differences in liver function after 6 weeks compared to placebo”
Source discussion ↗
“Uridine (UMP)+DHA, Bacopa monnieri, kava”
Source discussion ↗
Top discussions (5)

Other options for anxiety

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate